Keynote Address

   Donald Berry, The University of Texas M.D. Anderson Cancer Center
New Developments in Bayesian Clinical Trials

Tutorials

   Steven Bai, Food and Drug Administration
Adapting Designs: Sample Size Re-estimation

   Yuan Ji, The University of Texas M.D. Anderson Cancer Center
Bayesian Adaptive Designs for Early Phase Clinical Trials

   George Kordzakhia, Food and Drug Administration
Bonferroni-Based Tree-Structured Gatekeeping Testing Procedures

   Ilya Lipkovich, Eli Lilly and Company
Identification of Promising Subgroups in the Retrospective Analysis of Clinical Trials

   Ying Lu, University of California, San Francisco
Statistical Considerations of Using Medical Imaging Techniques in Clinical Trials

   Susan Parker, Bristol-Myers Squibb Company and Lixin Lang, Bristol-Myers Squibb Company
Phase I Oncology Designs: Comparisons and Extensions

   David Raunig, Pfizer, Inc and Patricia English, Pfizer, Inc.
Imaging Basics

   Ramses Sadek, American College of Radiology
Patient Reported Outcome/Quality of Life Assessment in Clinical Trails

   Andreas Sashegyi, Eli Lilly and Company
Application of Learning Maps in Pharmaceutical Research and Development

   Jerald Schindler, Merck Research Laboratories
Adaptive Trials: Unlocking the Opportunity and the Competitive Advantage

   Takashi Sozu, Osaka University
Power and Sample Size Calculations in Clinical Trials with Multiple Co-primary Endpoints

   Shumei S. Sun, Virginia Comonwealth University
A Double Blind, Two-Arm Placebo Controlled Trial of Alendronate in Patients with Gaucher's Disease

   Long Wang, GlaxoSmithKline Pharmaceuticals
Validation of Bioanalytical Assay

   Yonghua Wang, Bristol-Myers Squibb Company
Effective Use of Data in Incomplete Crossover Designs: Theory and Application

   Yin Yin, GlaxoSmithKline Pharmaceuticals
Quantification in the Internal Decision Making Process

Short Courses (Wednesday 1:00 PM -- Friday 12:00 noon)

   Byron Jones, Pfizer Global Research and Development
The Design and Analysis of Cross-over Trials

   Stephan Ogenstad, Statogen Consulting LLC
Mathematical Modeling and Trial Simulation in Medicine and Life Sciences

   Naomi B. Robbins, NBR and Ana Szarfman, FDA
Creating More Effective Graphs with Applications to Clinical Trials and Electronic Medical Records